{"transactions":[{"id":678456,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-21T23:45:28.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":44964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of (i) August 14, 2027, and (ii) immediately prior to the Registrant's next Annual Meeting of Stockholders following the date of grant, subject to the Reporting Person's continuous service through the applicable vesting date, inclusive."}],"balance_after":44964,"derivative":{"exercise_price":6.54,"expiration_date":"2036-08-14","underlying":"Common Stock","underlying_shares":44964},"source":{"system":"sec-edgar","filing":"0001193125-26-361482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680739/000119312526361482/ownership.xml","form_type":"4"}},{"id":722587,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T00:05:05.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":20158,"source":{"system":"sec-edgar","filing":"0001680739-26-000015","document":"form4-06302026_080601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073926000015/form4-06302026_080601.xml","form_type":"4"}},{"id":722586,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T00:05:05.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":1571,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 11, 2027. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":20083,"source":{"system":"sec-edgar","filing":"0001680739-26-000015","document":"form4-06302026_080601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073926000015/form4-06302026_080601.xml","form_type":"4"}},{"id":736057,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-16T20:42:53.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":21.38,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001680739-26-000014","document":"form4-06162026_080649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000014/form4-06162026_080649.xml","form_type":"4"}},{"id":736056,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:42:53.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":50,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person."}],"balance_after":41500,"source":{"system":"sec-edgar","filing":"0001680739-26-000014","document":"form4-06162026_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000014/form4-06162026_080649.xml","form_type":"4"}},{"id":736055,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:42:53.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":true,"shares":4500,"price":21.38,"value":96210.0,"ownership":{"direct":true},"balance_after":46000,"source":{"system":"sec-edgar","filing":"0001680739-26-000014","document":"form4-06162026_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000014/form4-06162026_080649.xml","form_type":"4"}},{"id":767800,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-21T21:00:06.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12000,"derivative":{"exercise_price":42.26,"exercise_date":"2027-05-19","expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001680739-26-000012","document":"form4-05212026_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000012/form4-05212026_050501.xml","form_type":"4"}},{"id":767799,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T21:00:06.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":41500,"source":{"system":"sec-edgar","filing":"0001680739-26-000012","document":"form4-05212026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000012/form4-05212026_050501.xml","form_type":"4"}},{"id":776697,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T21:42:16.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":31250,"derivative":{"exercise_price":15.86,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001680739-26-000010","document":"wk-form4_1778881334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000168073926000010/wk-form4_1778881334.xml","form_type":"4"}},{"id":789870,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-07T00:00:35.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.27,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001680739-26-000008","document":"form4-05062026_080518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000008/form4-05062026_080518.xml","form_type":"4"}},{"id":789869,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T00:00:35.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":46.65,"value":209925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001680739-26-000008","document":"form4-05062026_080518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000008/form4-05062026_080518.xml","form_type":"4"}},{"id":789868,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T00:00:35.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":4500,"price":18.27,"value":82215.0,"ownership":{"direct":true},"balance_after":42000,"source":{"system":"sec-edgar","filing":"0001680739-26-000008","document":"form4-05062026_080518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000008/form4-05062026_080518.xml","form_type":"4"}},{"id":793717,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-04T20:27:24.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":9750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":9750,"derivative":{"exercise_price":6.82,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":9750},"source":{"system":"sec-edgar","filing":"0001680739-26-000007","document":"form4-05042026_080519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000007/form4-05042026_080519.xml","form_type":"4"}},{"id":793716,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:27:24.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":9750,"price":44.22,"value":431145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001680739-26-000007","document":"form4-05042026_080519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000007/form4-05042026_080519.xml","form_type":"4"}},{"id":793715,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:27:24.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":9750,"price":6.82,"value":66495.0,"ownership":{"direct":true},"balance_after":47250,"source":{"system":"sec-edgar","filing":"0001680739-26-000007","document":"form4-05042026_080519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000007/form4-05042026_080519.xml","form_type":"4"}},{"id":798593,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-29T00:35:05.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18512,"source":{"system":"sec-edgar","filing":"0001680739-26-000006","document":"form4-04282026_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073926000006/form4-04282026_080401.xml","form_type":"4"}},{"id":806965,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":false,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":6750,"derivative":{"exercise_price":17.11,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806964,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":4500,"derivative":{"exercise_price":21.38,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806963,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":4500,"derivative":{"exercise_price":18.27,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806962,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.43,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806961,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.94,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806960,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":6750,"price":42.12,"value":284310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806959,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":26000,"price":41.07,"value":1067820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person."}],"balance_after":44250,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806958,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":true,"shares":6750,"price":17.11,"value":115492.5,"ownership":{"direct":true},"balance_after":70250,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806957,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":true,"shares":4500,"price":21.38,"value":96210.0,"ownership":{"direct":true},"balance_after":63500,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806956,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":true,"shares":4500,"price":18.27,"value":82215.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806955,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":15.43,"value":138870.0,"ownership":{"direct":true},"balance_after":54500,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":806954,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:15.000Z","date":"2026-04-14","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":17.94,"value":143520.0,"ownership":{"direct":true},"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001680739-26-000005","document":"form4-04162026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000005/form4-04162026_040405.xml","form_type":"4"}},{"id":813351,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-04-07T22:17:22.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001680739-26-000003","document":"form4-04072026_100418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000003/form4-04072026_100418.xml","form_type":"4"}},{"id":813350,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-07T22:17:22.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":33,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on May 9, 2018."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001680739-26-000003","document":"form4-04072026_100418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000003/form4-04072026_100418.xml","form_type":"4"}},{"id":813349,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-07T22:17:22.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":26.52,"value":265200.0,"ownership":{"direct":true},"balance_after":47500,"source":{"system":"sec-edgar","filing":"0001680739-26-000003","document":"form4-04072026_100418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000168073926000003/form4-04072026_100418.xml","form_type":"4"}},{"id":861922,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T21:59:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":134088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date."}],"balance_after":134088,"derivative":{"exercise_price":14.88,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":134088},"source":{"system":"sec-edgar","filing":"0001193125-26-091770","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526091770/ownership.xml","form_type":"4"}},{"id":921035,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T01:35:05.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":70,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18429,"source":{"system":"sec-edgar","filing":"0001680739-26-000001","document":"form4-02032026_080202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073926000001/form4-02032026_080202.xml","form_type":"4"}},{"id":991021,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":false,"shares":7068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option shares are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":41.19,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":7068},"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991020,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option shares are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":40.93,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991019,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":false,"shares":5112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option shares are fully exercisable."}],"balance_after":600,"derivative":{"exercise_price":40.93,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5112},"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991018,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":1884,"price":224.886,"value":423685.224,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.72 to $224.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18359,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991017,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":223.9037,"value":425417.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.49 to $224.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20243,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991016,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":222.9,"value":401220.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.46 to $223.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22143,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991015,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":900,"price":221.8133,"value":199631.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23943,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991014,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":1184,"price":220.1402,"value":260645.9968,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":24843,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991013,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":true,"shares":7068,"price":41.19,"value":291130.92,"ownership":{"direct":true},"balance_after":26027,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991012,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":true,"shares":600,"price":40.93,"value":24558.0,"ownership":{"direct":true},"balance_after":18959,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991011,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":2135,"price":216.0673,"value":461303.6855,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.55 to $216.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18359,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991010,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":1727,"price":214.7921,"value":370945.9567,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.35 to $215.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20494,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991009,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":1250,"price":213.471,"value":266838.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.18 to $214.1550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22221,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":991008,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T01:05:05.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":true,"shares":5112,"price":40.93,"value":209234.16,"ownership":{"direct":true},"balance_after":23471,"source":{"system":"sec-edgar","filing":"0001680739-25-000007","document":"form4-11212025_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000007/form4-11212025_081101.xml","form_type":"4"}},{"id":1007832,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T02:05:05.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18359,"source":{"system":"sec-edgar","filing":"0001680739-25-000005","document":"form4-11042025_091101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000168073925000005/form4-11042025_091101.xml","form_type":"4"}},{"id":1079621,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-30T01:05:05.000Z","date":"2025-07-25","kind":"grant","planned":false,"acquired":true,"shares":108,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18266,"source":{"system":"sec-edgar","filing":"0001415889-25-020514","document":"form4-07292025_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588925020514/form4-07292025_090701.xml","form_type":"4"}},{"id":1097567,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T01:15:05.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":2143,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2026. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18158,"source":{"system":"sec-edgar","filing":"0001415889-25-018834","document":"form4-07012025_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588925018834/form4-07012025_090701.xml","form_type":"4"}},{"id":1110987,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:05:10.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":30508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on June 11, 2026, subject to the Reporting Person's continuous service through the vesting date, inclusive."}],"balance_after":30508,"derivative":{"exercise_price":11.29,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":30508},"source":{"system":"sec-edgar","filing":"0000950170-25-086141","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680739/000095017025086141/ownership.xml","form_type":"4"}},{"id":1142004,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-19T21:32:33.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 19, 2026, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.51,"expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001549595-25-000077","document":"wk-form4_1747690345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959525000077/wk-form4_1747690345.xml","form_type":"4"}},{"id":1145188,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-05-16T23:00:07.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":21.15,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-25-013496","document":"form4-05162025_070503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013496/form4-05162025_070503.xml","form_type":"4"}},{"id":1145187,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T23:00:07.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001415889-25-013496","document":"form4-05162025_070503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013496/form4-05162025_070503.xml","form_type":"4"}},{"id":1163759,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-30T00:35:05.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $16,875 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":16015,"source":{"system":"sec-edgar","filing":"0001415889-25-011550","document":"form4-04292025_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588925011550/form4-04292025_080401.xml","form_type":"4"}},{"id":1207451,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-03-13T20:09:03.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning April 11, 2025, until the option is fully vested on March 11, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":13.9,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001549595-25-000045","document":"wk-form4_1741896536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959525000045/wk-form4_1741896536.xml","form_type":"4"}},{"id":1276402,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-10T23:04:17.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.44,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-003529","document":"form4-02102025_110214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925003529/form4-02102025_110214.xml","form_type":"4"}},{"id":1276401,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-10T23:04:17.000Z","date":"2025-02-06","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":22,"value":220000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on August 16, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001415889-25-003529","document":"form4-02102025_110214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925003529/form4-02102025_110214.xml","form_type":"4"}},{"id":1276400,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-10T23:04:17.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":17.44,"value":174400.0,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001415889-25-003529","document":"form4-02102025_110214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925003529/form4-02102025_110214.xml","form_type":"4"}},{"id":1283711,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-05T02:15:06.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":15899,"source":{"system":"sec-edgar","filing":"0001415889-25-003068","document":"form4-02042025_090201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588925003068/form4-02042025_090201.xml","form_type":"4"}},{"id":1296291,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-24T01:36:55.000Z","date":"2025-01-23","kind":"exercise","planned":true,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.5,"expiration_date":"2026-07-19","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001415889-25-002003","document":"form4-01242025_010152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925002003/form4-01242025_010152.xml","form_type":"4"}},{"id":1296290,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-24T01:36:55.000Z","date":"2025-01-23","kind":"sale","planned":true,"acquired":false,"shares":16000,"price":20,"value":320000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on August 16, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person on July 19, 2016, with an expiration date of July 19, 2026."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001415889-25-002003","document":"form4-01242025_010152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925002003/form4-01242025_010152.xml","form_type":"4"}},{"id":1296289,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-24T01:36:55.000Z","date":"2025-01-23","kind":"exercise","planned":true,"acquired":true,"shares":16000,"price":17.5,"value":280000.0,"ownership":{"direct":true},"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001415889-25-002003","document":"form4-01242025_010152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925002003/form4-01242025_010152.xml","form_type":"4"}},{"id":1363200,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"exercise","planned":true,"acquired":false,"shares":15230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option shares are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.42,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":15230},"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363199,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"exercise","planned":true,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option shares are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":22.83,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363198,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":1983,"price":149.9788,"value":297407.9604,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.87 to $150.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15807,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363197,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":2106,"price":148.7415,"value":313249.599,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.35 to $149.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17790,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363196,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":9467,"price":147.3138,"value":1394619.7446,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.067 to $147.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":19896,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363195,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":1770,"price":146.255,"value":258871.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.87 to $146.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":29363,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363194,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":16404,"price":145.2083,"value":2381996.9532,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.85 to $145.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31133,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363193,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":144.258,"value":793419.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.81 to $144.70 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47537,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363192,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"exercise","planned":true,"acquired":true,"shares":15230,"price":24.42,"value":371916.6,"ownership":{"direct":true},"balance_after":53037,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1363191,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-16T02:50:08.000Z","date":"2024-11-15","kind":"exercise","planned":true,"acquired":true,"shares":22000,"price":22.83,"value":502260.0,"ownership":{"direct":true},"balance_after":37807,"source":{"system":"sec-edgar","filing":"0001415889-24-027020","document":"form4-11152024_091103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924027020/form4-11152024_091103.xml","form_type":"4"}},{"id":1379894,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-30T01:05:05.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":124,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":15807,"source":{"system":"sec-edgar","filing":"0001415889-24-025713","document":"form4-10292024_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924025713/form4-10292024_091001.xml","form_type":"4"}},{"id":1446064,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-31T01:05:06.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":143,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":15683,"source":{"system":"sec-edgar","filing":"0001415889-24-020382","document":"form4-07302024_090702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924020382/form4-07302024_090702.xml","form_type":"4"}},{"id":1462071,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T01:05:05.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":2964,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2025. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":15540,"source":{"system":"sec-edgar","filing":"0001415889-24-019063","document":"form4-07022024_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924019063/form4-07022024_090701.xml","form_type":"4"}},{"id":1520558,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-10T20:05:17.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":6.82,"exercise_date":"2025-05-08","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-24-012844","document":"form4-05102024_040510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012844/form4-05102024_040510.xml","form_type":"4"}},{"id":1520557,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:05:17.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001415889-24-012844","document":"form4-05102024_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012844/form4-05102024_040510.xml","form_type":"4"}},{"id":1532683,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T00:35:25.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":169,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":12576,"source":{"system":"sec-edgar","filing":"0001415889-24-011829","document":"form4-04302024_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924011829/form4-04302024_080413.xml","form_type":"4"}},{"id":1666257,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T01:05:05.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":215,"price":63.79,"value":13714.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $13,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":12407,"source":{"system":"sec-edgar","filing":"0001415889-24-001998","document":"form4-01302024_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588924001998/form4-01302024_080101.xml","form_type":"4"}},{"id":1753017,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-01T01:05:10.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":322,"price":42.6,"value":13717.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $13,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":12192,"source":{"system":"sec-edgar","filing":"0001415889-23-014635","document":"form4-10312023_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923014635/form4-10312023_091001.xml","form_type":"4"}},{"id":1818944,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T01:05:09.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":264,"price":48.48,"value":12798.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $12,802.20 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":11870,"source":{"system":"sec-edgar","filing":"0001415889-23-011685","document":"form4-08012023_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923011685/form4-08012023_090801.xml","form_type":"4"}},{"id":1835181,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-06T01:05:06.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":4255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest and become exercisable in full on June 9, 2024. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control."}],"balance_after":4255,"derivative":{"exercise_price":48.66,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":4255},"source":{"system":"sec-edgar","filing":"0001415889-23-010848","document":"form4-07052023_090701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923010848/form4-07052023_090701.xml","form_type":"4"}},{"id":1835180,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T01:05:06.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 9, 2024. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":11606,"source":{"system":"sec-edgar","filing":"0001415889-23-010848","document":"form4-07052023_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923010848/form4-07052023_090701.xml","form_type":"4"}},{"id":1875928,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-27T01:05:18.000Z","date":"2023-05-25","kind":"exercise","planned":false,"acquired":false,"shares":3534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU vested in full on May 25, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU vested in full on May 25, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3534},"source":{"system":"sec-edgar","filing":"0001415889-23-008882","document":"form4-05262023_090501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923008882/form4-05262023_090501.xml","form_type":"4"}},{"id":1875927,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-27T01:05:18.000Z","date":"2023-05-25","kind":"exercise","planned":false,"acquired":true,"shares":3534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":8856,"source":{"system":"sec-edgar","filing":"0001415889-23-008882","document":"form4-05262023_090501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923008882/form4-05262023_090501.xml","form_type":"4"}},{"id":1884452,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-19T20:06:09.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":13500,"derivative":{"exercise_price":17.11,"exercise_date":"2024-05-17","expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-23-030967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030967/doc4.xml","form_type":"4"}},{"id":1884451,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:06:09.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001209191-23-030967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030967/doc4.xml","form_type":"4"}},{"id":1917853,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T00:10:07.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":228,"price":54.73,"value":12478.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $12,500 for service on the Issuer's Board of Directors.  The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5322,"source":{"system":"sec-edgar","filing":"0001415889-23-006656","document":"form4-04182023_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923006656/form4-04182023_080401.xml","form_type":"4"}},{"id":2052094,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T02:35:10.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":312,"price":40.01,"value":12483.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $12,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5094,"source":{"system":"sec-edgar","filing":"0001415889-23-001143","document":"form4-01182023_090101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588923001143/form4-01182023_090101.xml","form_type":"4"}},{"id":2135319,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-19T01:05:36.000Z","date":"2022-10-14","kind":"grant","acquired":true,"shares":275,"price":45.42,"value":12490.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $12,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":4782,"source":{"system":"sec-edgar","filing":"0001415889-22-010696","document":"form4-10182022_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922010696/form4-10182022_091001.xml","form_type":"4"}},{"id":2167100,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-03T00:05:10.000Z","date":"2022-07-08","kind":"grant","acquired":true,"shares":344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $12,500 for service on the Issuer's Board of Directors.  The previously filed Form 4 inadvertently reported the transaction on Table II.  The RSUs were fully-vested at the time of issuance and should have been reported on Table I as reflected in this amendment.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":4507,"source":{"system":"sec-edgar","filing":"0001415889-22-009317","document":"form4a-09022022_080901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922009317/form4a-09022022_080901.xml","form_type":"4/A","original_submission_date":"2022-07-12"}},{"id":2208442,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-13T01:05:10.000Z","date":"2022-07-08","kind":"grant","acquired":true,"shares":344,"price":36.31,"value":12490.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were issued to the Reporting Person in lieu of retainer fees of $12,500 for service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are fully vested and may be exercised at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are fully vested and may be exercised at any time."}],"balance_after":344,"derivative":{"underlying":"Common Stock","underlying_shares":344},"source":{"system":"sec-edgar","filing":"0001415889-22-007643","document":"form4-07122022_090701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922007643/form4-07122022_090701.xml","form_type":"4"}},{"id":2220872,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-06-27T20:48:09.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":31500,"derivative":{"exercise_price":7.35,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001140361-22-024161","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036122024161/form4.xml","form_type":"4"}},{"id":2220871,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-27T20:48:09.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":43500,"source":{"system":"sec-edgar","filing":"0001140361-22-024161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036122024161/form4.xml","form_type":"4"}},{"id":2249055,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T01:05:40.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":7068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest and become exercisable in full on May 25, 2023. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control."}],"balance_after":7068,"derivative":{"exercise_price":41.19,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":7068},"source":{"system":"sec-edgar","filing":"0001415889-22-006008","document":"form4-06012022_090621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922006008/form4-06012022_090621.xml","form_type":"4"}},{"id":2249054,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-02T01:05:40.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":3534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU shall vest in full on May 25, 2023. The RSU will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU shall vest in full on May 25, 2023. The RSU will become fully vested in the event that the Issuer is subject to a change in control."}],"balance_after":3534,"derivative":{"underlying":"Common Stock","underlying_shares":3534},"source":{"system":"sec-edgar","filing":"0001415889-22-006008","document":"form4-06012022_090621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922006008/form4-06012022_090621.xml","form_type":"4"}},{"id":2252724,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-28T01:45:29.000Z","date":"2022-05-25","kind":"exercise","acquired":false,"shares":1307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU vested in full on May 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU vested in full on May 25, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1307},"source":{"system":"sec-edgar","filing":"0001415889-22-005858","document":"form4-05272022_090501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922005858/form4-05272022_090501.xml","form_type":"4"}},{"id":2252723,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T01:45:29.000Z","date":"2022-05-25","kind":"exercise","acquired":true,"shares":1307,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":4163,"source":{"system":"sec-edgar","filing":"0001415889-22-005858","document":"form4-05272022_090501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604821/000141588922005858/form4-05272022_090501.xml","form_type":"4"}},{"id":2273409,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":20734,"kind":"person","name":"Baynes Roy D.","position":1,"cik":"0001680739","reported_name":"Baynes Roy D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-13T00:18:15.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":21.38,"exercise_date":"2023-05-11","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-028685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028685/doc4.xml","form_type":"4"}}],"next_cursor":"2022-05-13T00:18:15.000000Z,2273409"}